Source: GlobalNewswire

Press Release: Zosano Pharma : Zosano Pharma Announces Presentation and Participation at the 31st Annual Roth Conference

FREMONT, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its chairman, president and chief executive officer, John Walker, will participate in a panel titled "Drug Delivery" to be held on Monday, March 18, 2019 at 10:30 am PT at the 31st Annual Roth Conference.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Steven Lo's photo - President & CEO of Zosano Pharma

President & CEO

Steven Lo

CEO Approval Rating

83/100

Zosano Pharma is a clinical-stage biopharmaceutical company that researches, develops and commercializes novel therapeutics to treat migraines. Read more